Mazor Robotics Ltd. (MZOR) to Post Q3 2016 Earnings of ($0.16) Per Share, First Analysis Forecasts
Mazor Robotics Ltd. (NASDAQ:MZOR) – Analysts at First Analysis lifted their Q3 2016 EPS estimates for Mazor Robotics in a research note issued to investors on Thursday. First Analysis analyst G. Chodaczek now anticipates that the firm will post earnings per share of ($0.16) for the quarter, up from their previous forecast of ($0.20). First Analysis also issued estimates for Mazor Robotics’ Q4 2016 earnings at ($0.06) EPS, FY2016 earnings at ($0.61) EPS, Q1 2017 earnings at ($0.12) EPS, Q2 2017 earnings at ($0.07) EPS and FY2017 earnings at ($0.25) EPS.
Mazor Robotics (NASDAQ:MZOR) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported ($0.09) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.02. The company had revenue of $8.30 million for the quarter, compared to analyst estimates of $8.51 million. Mazor Robotics had a negative return on equity of 42.30% and a negative net margin of 60.75%. The business’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.05) earnings per share.
MZOR has been the topic of a number of other research reports. Needham & Company LLC reiterated a “hold” rating on shares of Mazor Robotics in a research note on Thursday, July 7th. Barclays PLC increased their target price on Mazor Robotics from $16.00 to $23.00 and gave the stock an “overweight” rating in a research note on Thursday, July 14th. Standpoint Research assumed coverage on Mazor Robotics in a research note on Friday, July 8th. They set a “buy” rating and a $30.00 target price on the stock. Zacks Investment Research lowered Mazor Robotics from a “hold” rating to a “sell” rating in a research note on Friday. Finally, B. Riley assumed coverage on Mazor Robotics in a research note on Thursday, October 6th. They set a “neutral” rating and a $25.00 target price on the stock. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $26.25.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/17/mazor-robotics-ltd-mzor-to-post-q3-2016-earnings-of-0-16-per-share-first-analysis-forecasts.html
Mazor Robotics (NASDAQ:MZOR) opened at 23.75 on Monday. Mazor Robotics has a 1-year low of $8.31 and a 1-year high of $26.55. The firm’s market cap is $514.73 million. The firm has a 50-day moving average price of $23.40 and a 200-day moving average price of $18.37.
A number of institutional investors have recently bought and sold shares of the company. Cookson Peirce & Co. Inc. bought a new position in Mazor Robotics during the second quarter worth approximately $192,000. Trellus Management Company LLC raised its position in shares of Mazor Robotics by 11.6% in the second quarter. Trellus Management Company LLC now owns 23,982 shares of the company’s stock valued at $431,000 after buying an additional 2,500 shares during the last quarter. Menta Capital LLC raised its position in shares of Mazor Robotics by 81.9% in the first quarter. Menta Capital LLC now owns 37,482 shares of the company’s stock valued at $466,000 after buying an additional 16,879 shares during the last quarter. Candriam Luxembourg S.C.A. acquired a new position in shares of Mazor Robotics during the second quarter valued at about $1,079,000. Finally, Iguana Healthcare Management LLC raised its position in shares of Mazor Robotics by 384.6% in the first quarter. Iguana Healthcare Management LLC now owns 121,151 shares of the company’s stock valued at $1,507,000 after buying an additional 96,151 shares during the last quarter. Hedge funds and other institutional investors own 18.71% of the company’s stock.
Mazor Robotics Company Profile
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.